Health ❯ Mental Health ❯ Psychedelics

Psilocybin

Magic Mushrooms Research Therapeutic Use Clinical Trials Traumatic Brain Injury Perception Alteration Treatment for Depression Treatment-Resistant Depression Edibles Therapy-Resistant Depression

High-Dose Psilocybin Produces Temporary Gains in Advanced Alzheimer’s Patient

The supervised, peer‑reviewed case suggests psilocybin can briefly restore speech and mobility and is prompting calls for controlled trials.

Single High Dose of Psilocybin Linked to Short-Term Brain Changes and Improved Well-Being

Single High Dose of Psilocybin Tied to Lasting Brain Changes and Month-Later Well-Being

Psychedelic Therapies Gain Momentum After Trump Order

New Analysis Finds Psychedelic Therapy Matches Antidepressants for Major Depression

Bryan Johnson Livestreams High-Dose Psilocybin Session as Tech Luminaries Tune In

Bryan Johnson Takes High-Dose Psilocybin in Public Self-Experiment on Aging

Mushrooms Evolved Psilocybin Two Ways, Lab Study Confirms

UVic Review Finds Psychedelics Show Potential for Treating Concussions and Other TBIs

Study Finds Portland 'Magic Mushroom' Edibles Lacked Psilocybin, Hid Synthetic Drugs

Portland 'Magic Mushroom' Edibles Contained No Psilocybin, JAMA Study Finds

Wellness Retreat Death Linked to Psilocybin Use, Coroner Urges Education

Survey Finds Cannabis and Psychedelics Most Effective for Eating Disorder Symptom Relief

Psilocybin Anti-Aging Studies Advance Toward Human Trials

Trump’s Surgeon General Nominee Faces Scrutiny Over Psychedelic Advocacy and Inactive Medical License

Psilocybin Use in the U.S. Surges, Outpacing Cocaine and Raising Safety Concerns

Quebec Religious Group Seeks Legal Use of Magic Mushrooms in Ceremonies

Study Reveals Psilocybin's Impact on Brain Connectivity